Involvement of nitric oxide in fading of 5-hydroxytryptamine-induced vasocontraction.
This investigation was done to determine whether vascular nitric oxide is involved in the fading of 5-hydroxytryptamine (5-HT)-induced contraction of isolated aortic strips from rats. The 5-HT (100 microM)-induced contractile response showed a gradual decrease in tension after a plateau level had been attained. The degree of the fadeaway was less in strips without endothelium than in those with endothelium. Pretreatment with nitro-L-arginine (100 microM) or haemoglobin (10 microM) suppressed the fadeaway of 5-HT contraction in both types of strips, although the effect was less in strips without endothelium. In contrast to 5-HT contraction, phenylephrine (10 microM) contraction in the presence of endothelium did not begin fading away for at least 1 hr after stimulation. In strips precontracted with 5-HT (100 microM), relaxation induced by sodium nitroprusside (1-50 nM) was significantly higher than in those precontracted with phenylephrine (10 microM). There was no significant difference between the cyclic GMP levels at 1 hr after stimulation with phenylephrine (10 microM) and 5-HT (100 microM). These results suggest that decrease in vascular tone in rat aorta after the plateau of 5-HT contraction has been reached is in part due to nitric oxide derived from vascular endothelial and non-endothelial cells. The vascular tone decreases more quickly after the plateau in the case of 5-HT contraction than of phenylephrine contraction, which may be due to higher sensitivity of 5-HT contraction to nitric oxide.
Department of Hygiene, Hyogo College of Medicine, Japan.
I
I
Wakabayashi
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D006152:Cyclic GMP / Q000378:metabolism; D004730:Endothelium, Vascular / Q000502:physiology; D006454:Hemoglobins / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000503:physiopathology*; D009569:Nitric Oxide / Q000378:metabolism*; D019335:Nitroarginine; D010656:Phenylephrine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects
D006454:Hemoglobins; D012702:Serotonin Antagonists; D010656:Phenylephrine; D019335:Nitroarginine; D009569:Nitric Oxide; D012701:Serotonin; D001120:Arginine; D006152:Cyclic GMP